Kineta Board Member Makes Strategic Stock Moves Following Merger Approval

Rhea-AI Filing Summary

Director Richard Peters of Kineta reported multiple transactions on June 23-25, 2025:

• Exercised 12,500 stock options at $0.611 per share on June 23
• Disposed of 4,706 shares at $0.26 per share through share withholding (F code)
• Received 6,000 shares as a new grant on June 25 at $0 cost

The transactions were part of a broader corporate event involving a merger agreement between Kineta and TuHURA Biosciences. Per the Optionholder Treatment Agreement dated June 16, 2025, and following stockholder approval on June 23, 2025, Peters' options under the 2022 Equity Incentive Plan became fully vested.

Following these transactions, Peters directly owns 101,891 shares of Kineta common stock. The option exercise eliminated his remaining derivative securities position.

Insider Trade Summary

12,500 shares exercised/converted

Mixed 4 txns

Insider Peters Richard

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	6,000	$0.00	--
Exercise	Stock Option (Right to Buy)	12,500	$0.00	--
Exercise	Common Stock	12,500	$0.611	$8K
Tax Withholding	Common Stock	4,706	$0.26	$1K

Holdings After Transaction: Common Stock — 101,891 shares (Direct); Stock Option (Right to Buy) — 0 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Peters Richard

(Last) (First) (Middle)

C/O KINETA, INC.

7683 SE 27TH STREET, SUITE 481

(Street)

MERCER ISLAND WA 98040

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
KINETA, INC./DE [ KANT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/23/2025		M		12,500	A	$0.611	100,597	D
Common Stock	06/23/2025		F		4,706	D	$0.26	95,891	D
Common Stock	06/25/2025		A		6,000	A	$0	101,891	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.611	06/23/2025		M			12,500	(1)	09/03/2034	Common Stock	12,500	$0	0	D

Explanation of Responses:

1. Pursuant to the terms of (i) the Optionholder Treatment Agreement, dated June 16, 2025, by and between Kineta, Inc. (the "Company") and the Reporting Person, and (ii) the Agreement and Plan of Merger, dated as of December 11, 2024, by and among the Company, TuHURA Biosciences, Inc., a Nevada corporation ("TuHURA"), Hura Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of TuHURA, Hura Merger Sub II, a Delaware limited liability company and a wholly owned subsidiary of TuHURA, and Craig Philips, as representative of the stockholders of the Company, and as amended by that certain First Amendment to Agreement and Plan of Merger, dated May 5, 2025, as approved by the Company's stockholders at the Special Meeting of Stockholders held on June 23, 2025, the options granted to the Reporting Person under the 2022 Equity Incentive Plan became fully vested on June 23, 2025.

	/s/ Nanette Agustines, as Attorney-in-Fact	06/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Richard Peters make in KA stock on June 23, 2025?

On June 23, 2025, Richard Peters executed multiple transactions: He exercised 12,500 stock options at $0.611 per share (acquired), then disposed of 4,706 shares at $0.26 per share. Additionally, on June 25, 2025, he acquired 6,000 shares at $0.

How many shares of Kineta (KA) does Richard Peters own after these transactions?

Following all reported transactions, Richard Peters beneficially owns 101,891 shares of Kineta (KA) common stock directly.

What was the exercise price of the KA stock options that Richard Peters exercised?

Richard Peters exercised stock options with a strike price of $0.611 per share. These options were originally set to expire on September 3, 2034, but were exercised early on June 23, 2025.

Why did Richard Peters' KA stock options vest early in June 2025?

The stock options vested early on June 23, 2025, due to the Optionholder Treatment Agreement dated June 16, 2025, and the Agreement and Plan of Merger with TuHURA Biosciences, Inc., which was approved by stockholders at the Special Meeting on June 23, 2025.